Friday, December 05, 2025 | 03:00 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

US drugmaker Merck's Kenneth Frazier to step down as CEO in June-end

Frazier, 66, will remain with the drugmaker as executive chairman for a transition period to be determined by the board.

merck
premium

The grandson of a sharecropper, and son of a janitor, Frazier was set to retire in 2019, but the company scrapped a policy requiring CEOs to retire at the age of 65 | Photo: Reuters

Reuters
Merck & Co Inc said on Thursday Kenneth Frazier, one of only a handful of Black executives leading major US companies, would step down as chief executive officer at the end of June to be replaced by Chief Financial Officer Robert Davis.
 
Frazier, 66, will remain with the drugmaker as executive chairman for a transition period to be determined by the board.
 
Davis has been CFO of Merck since 2014 and has been in charge of the company's business development, real estate and other corporate strategic functions since 2016.
 
A career healthcare executive, he was the president of Baxter International